台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    109.0
  • 漲跌
    ▼6.5
  • 漲幅
    -5.63%
  • 成交量
    4,054
  • 產業
    上櫃 生技醫療類股
  • 310人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智擎 (4162)籌碼相關-凱基-三多 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-三多 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/02/262119.002117.75115.5001,5530.00%
2025/02/2500.002114.25113.00-21,443-0.14%
2025/02/241115.5000.00115.0011,4310.07%
2025/02/212112.7500.00113.0021,4120.14%
2025/02/1400.001110.00111.50-11,408-0.07%
2025/02/1280112.1300.00112.00801,4085.68%
2025/02/110111.2789110.08109.00-891,392-6.39%
2025/02/1036120.2800.00118.50361,3372.69%
2025/02/064119.253119.00119.0011,3290.08%
2025/02/0440102.42299.50103.00381,2013.16%
2025/01/09194.80195.2094.6001,3410.00%
2025/01/0700.002100.50101.50-21,275-0.16%
2024/12/16288.5000.0086.3021,2160.16%
2024/12/1300.00289.5088.80-21,209-0.17%
2024/12/0600.00493.4093.30-41,180-0.34%
2024/12/03494.8500.0094.4041,1610.34%
2024/11/29198.0000.0097.5011,1360.09%
2024/11/2800.00292.3092.40-21,110-0.18%
2024/11/22296.5000.0093.8021,0310.19%
2024/11/1500.000.1100.5099.90-0.1989-0.01%
2024/11/1400.001102.50101.50-1971-0.10%
2024/11/042104.0000.00100.0027580.26%
2024/10/291101.0000.00100.5016040.17%
2024/10/2800.00197.60102.00-1576-0.17%
2024/10/250.197.4000.0097.400.15130.02%
2024/10/241100.001100.0398.300494-0.01%
2024/10/23094.2000.0093.7004240.01%
2024/10/16189.40189.4089.4004760.00%
2024/10/0900.00290.9089.50-2508-0.39%
2024/09/2500.00389.9788.20-3609-0.49%
2024/09/04182.3000.0082.0016980.14%
2024/08/22186.7000.0086.6017400.14%
2024/07/2600.00197.2097.60-1729-0.14%
2024/07/18298.8500.0099.4026760.30%
2024/07/16197.0000.0097.0016580.15%
2024/07/1500.00198.6098.40-1663-0.15%
2024/07/11095.5000.0095.2006500.00%
2024/07/0200.00199.4097.80-1623-0.16%
2024/06/27196.0000.0095.7015820.17%
2024/06/0500.00292.7092.90-2632-0.32%
2024/06/03190.9000.0090.7016930.14%
2024/05/3100.00190.7090.60-1729-0.14%
2024/05/2700.00191.4091.70-1776-0.13%
2024/05/24293.0000.0092.8028080.25%
2024/05/22194.8000.0094.1018470.12%
2024/05/21196.9000.0095.1018500.12%
2024/05/2000.00198.0096.90-1865-0.12%
2024/05/1700.00397.0797.90-3872-0.34%
2024/05/06193.8000.0093.4011,1750.09%
2024/05/03193.80195.3093.8001,3640.00%
2024/05/02193.70194.9094.9001,4140.00%
2024/04/30293.70496.0093.70-21,425-0.14%
2024/04/1900.00491.1889.00-41,523-0.26%
2024/04/17192.70192.2092.6001,5410.00%
2024/04/16293.5000.0091.0021,5570.13%
2024/04/03298.9000.0099.0021,7770.11%
2024/04/0200.001100.5098.90-11,780-0.06%
2024/03/29199.4000.0099.2011,8130.06%
2024/03/28199.402100.0099.40-11,839-0.05%
2024/03/27196.8000.0099.7011,8280.05%
2024/03/26299.0000.0096.8021,8180.11%
2024/03/251101.00199.60101.0001,8160.00%
2024/03/2200.00196.1096.50-11,801-0.06%
2024/03/21195.8000.0096.0011,8270.05%
2024/03/2000.00195.6095.80-11,855-0.05%
2024/03/1300.00195.9092.40-11,896-0.05%
2024/03/1200.00195.6095.60-11,889-0.05%
2024/03/11195.1000.0095.1011,9040.05%
2024/03/0800.00395.6095.10-31,924-0.16%
2024/03/07297.4000.0099.3021,9300.10%
2024/03/06198.5000.0098.1011,9370.05%
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-25天前
智擎 相關文章